Evidence map›Paper›PMID 28619776›Full record

ArticleBMJ open2017

A cross-sectional study of the prevalence, awareness, treatment and control of hypertension in Shenzhen, China.

Haitao Li, Xinfeng Yan, Xiaoting Deng, Lizhen Yang, Shaojuan Zhao, Jianfeng Zou, Yi Luo, Sijing Cao

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Haitao LiSchool of Medicine, Shenzhen University, Shenzhen, China.
Xinfeng YanLonghua District Center for Chronic Disease Prevention and Control, Shenzhen, China.
Xiaoting DengLonghua District Center for Chronic Disease Prevention and Control, Shenzhen, China.
Lizhen YangLonghua District Center for Chronic Disease Prevention and Control, Shenzhen, China.
Shaojuan ZhaoLonghua District Center for Chronic Disease Prevention and Control, Shenzhen, China.
Jianfeng ZouLonghua District Center for Chronic Disease Prevention and Control, Shenzhen, China.
Yi LuoLonghua District Center for Chronic Disease Prevention and Control, Shenzhen, China.
Sijing CaoLonghua District Center for Chronic Disease Prevention and Control, Shenzhen, China.
Shenzhen Nanshan Center for Chronic Disease Control · CNShenzhen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesAn understanding of the awareness, treatment and control of hypertension is helpful to guide decision-making regarding interventions to reduce the risk for diseases with hypertension as a key risk factor. This study aimed to estimate the prevalence, awareness, treatment, and control of hypertension in Shenzhen, China.

methodsA cross-sectional study was conducted. We employed multistage cluster random sampling methods to select participants. A survey involving face-to-face interviews was conducted to collect the data. A total of 1676 participants finished the survey and formed the final analysis.

resultsWe found that the prevalence of hypertension was 17.6%. The rates of hypertension awareness, treatment and control were 48.8%, 51.4% and 43.2% respectively. Only 6.8% hypertensives were found to be managed by community health centres. Compared with the female participants, the males were found to have higher rates of prevalence (19.7% vs 15.7%; OR 1.47, 95% CI 1.10 to 1.97) and awareness (42.9% vs 38.1%; OR 2.35, 95% CI 1.28 to 4.33), but lower rates of medication treatments (20.5% vs 30.2%; OR 0.83, 95% CI 0.05 to 0.92) and control (12.8% vs 23.0%; OR 0.45, 95% CI 0.21 to 0.96). Migrants were more likely to be aware of hypertension (32.5% vs 44.3%; OR 0.57, 95% CI 0.30 to 0.90), reduce their salt intake (8.8% vs 18.1%; OR 0.40, 95% CI 0.15 to 0.94), and undertake regular monitoring of hypertension (1.3% vs 11.0%; OR 0.14, 95% CI 0.02 to 0.92) when compared with the locals.

conclusionsOur study finds that hypertension is an important public health burden in Shenzhen. It implies that strategies need to be developed to improve effective primary care management of hypertension. It also suggests a need to develop gender and household register tailored strategies for the prevention, detection, treatment and control of hypertension.

Indexed as

Primary Health CareAdultAgedAntihypertensive AgentsBlood Pressure Monitoring, AmbulatoryChinaCluster AnalysisCross-Sectional StudiesFemaleHealth Knowledge, Attitudes, PracticeHealth Services AccessibilityHumansHypertensionMaleMiddle AgedPrevalenceAntihypertensive Agentsawarenesscontrolhypertensionprevalencetreatment

Identifiers

PMID28619776
PMCPMC5734397
OpenAlexW2625669503

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.